Concepedia

Publication | Open Access

Daratumumab as Single Agent in Relapsed/Refractory Myeloma Patients: A Retrospective Real-Life Survey

DOIFull Paper Access

11

Citations

33

References

2021

Year

Uroš Markovic, Alessandra Romano, Vittorio Del Fabro, Claudia Bellofiore, Anna Bulla, Marina Parisi, Salvatore Leotta, Massimo Gentile, Clotilde Cangialosi, Iolanda Donatella Vincelli,
Frontiers in Oncology

Abstract

Our findings indicate that daratumumab as single agent is safe and well-tolerated regimen in real-life, associated to prolonged PFS and OS in responding patients. No new safety signals were identified.

References

YearCitations

Page 1